Segments of Puumala Hantavirus Nucleocapsid Protein Inserted into Chimeric Polyomavirus-Derived Virus-Like Particles Induce a Strong Immune Response in Mice

Viral Immunology

Volumn 17, Issue 1, 2004, Pages 51-68

  Gedvilaite, Alma ^a   Zvirbliene, Aurelija ^a   Staniulis, Juozas ^b   Sasnauskas, Kestutis ^a   Krüger, Detlev H ^c   Ulrich, Rainer ^c  

^a VILNIUS UNIVERSITY   (Lithuania)

^b INSTITUTE OF BOTANY   (Lithuania)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HANTAVIRUS NUCLEOCAPSID PROTEIN VACCINE; NUCLEOCAPSID PROTEIN; PROTEIN VP1; UNCLASSIFIED DRUG; VIRUS VACCINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; GENE INSERTION; HANTAVIRUS; IMMUNE RESPONSE; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PUUMALA VIRUS; TH1 CELL; TH2 CELL; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CRICETINAE; IMMUNIZATION; MALE; MICE; MICE, INBRED BALB C; NUCLEOCAPSID; NUCLEOCAPSID PROTEINS; POLYOMAVIRUS; PUUMALA VIRUS; RECOMBINANT FUSION PROTEINS; TH1 CELLS; TH2 CELLS; VIRAL VACCINES; VIRION;

ANIMALIA; CRICETINAE; HAMSTER POLYOMAVIRUS; HANTAVIRUS; INSERTION SEQUENCES; POLYOMAVIRUS; PUUMALA VIRUS; RNA VIRUSES;

EID: 1542513302     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282404322875458     Document Type: Article

References (56)

1. Ada, G., and A. Ramsay. 1997. Vaccines, Vaccination and the Immune Response. Lippincott-Raven, New York.
2. Adams, S.E., K.M. Dawson, K. Gull, et al. 1987. The expression of hybrid HIV:Ty virus-like particles in yeast. Nature 329:68-70.
3. Ball, J.M., D.Y. Graham, A.R. Opekun, et al. 1999. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology 117:40-48.
4. Berry, J.M., and J.M. Palefsky. 2003. A review of human papillomavirus vaccines: from basic science to clinical trials. Front. Biosci. 8:s333-s345.
5. Bostic, J.R., K.E. Brown, N.S. Young, et al. 1999. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay. J. Infect. Dis. 179:619-626.
6. Ciarlet, M., S.E. Crawford, C. Barone, et al. 1998. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J. Virol. 72:9233-9246.
7. Dargeviciute, A., K. Brus Sjölander, K. Sasnauskas, et al. 2002. Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine 20:3523-3531.
8. de Carvalho Nicacio, C., M. Sällberg, C. Hultgren, et al. 2001. T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: Identification of T-helper epitopes in a mouse model. J. Gen. Virol. 82:129-138.
9. Elgh, F., Å. Lundkvist, O.A. Alexeyev, et al. 1996. A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus. J. Virol. Methods 59:161-172.
10. Forstova, J., N. Krauzewicz, V. Sandig, et al. 1995. Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum. Gene Ther. 6:297-306.
11. Francis, M.J., G.Z. Hastings, A.L. Brown, et al. 1990. Immunological properties of hepatitis B core antigen fusion proteins. Proc. Natl. Acad. Sci. USA 87:2545-2549.
12. Garcea, R.L., D.M. Salunke, and D.L. Caspar. 1987. Site-directed mutation affecting polyomavirus capsid self-assembly in vitro. Nature 329:86-87.
13. Gedvilaite, A., C. Frömmel, K. Sasnauskas, et al. 2000. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Virology 273:21-35.
14. Gerlich, W.H., D.H. Krüger, and R. Ulrich (eds.) 1996. Chimeric virus-like particles as vaccines [Special issue]. Intervirology 39, no. 1-2.
15. Gleiter, S., K. Stubenrauch, and H. Lilie. 1999. Changing the surface of a virus shell fusion of an enzyme to polyoma VP1. Protein Sci. 8:2562-2569.
16. Gött, P., L. Zöller, G. Darai, et al. 1997. A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein. Virus Genes 14:31-40.
17. Goldmann, C., H. Petry, S. Frye, et al. 1999. Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. J. Virol. 73:4465-4469.
18. Griffiths, J.C., S.J. Harris, G.T. Layton, et al. 1993. Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: Induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. J. Virol. 67:3191-3198.
19. Jenison, S., T. Yamada, C. Morris, et al. 1994. Characterization of human antibody responses to Four Comers hantavirus infections among patients with hantavirus pulmonary syndrome. J. Virol. 68:3000-3006.
20. Koletzki, D., S.S. Biel, H. Meisel, et al. 1999. HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein. Biol. Chem. 380:325-333.
21. Koletzki, D., Å. Lundkvist, K. Brus Sjölander, et al. 2000. Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles. Virology 276:364-375.
22. Kratz, P.A., B. Böttcher, and M. Nassal. 1999. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc. Natl. Acad. Sci. USA 96:1915-1020.
23. Krüger, D.H., R. Ulrich, and W.H. Gerlich (eds.). 1999. [Special issue]. Biol. Chem. 380, no. 3.
24. Langner, J., H. Zentgraf, and M. Pawlita. 1998. Viral particles with heterologous binding motifs. An approach to specifically alter the tropism of the B-lymphotropic papovavirus. Adv. Exp. Med. Biol. 451:415-422.
25. Lechner, F., A. Jegerlehner, A.C. Tissot, et al. 2002. Virus-like particles as a modular system for novel vaccines. Intervirology 45:212-217.
26. Lenz, P., P.M. Day, Y.Y. Pang, et al. 2001. Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 166:5346-5355.
27. Lowy, D.R., and J.T. Schiller. 1999. Papillomaviruses: prophylactic vaccine prospects. Biochim. Biophys. Acta 1423:1-8.
28. Lundkvist, Å., A. Fatouros, and B. Niklasson. 1991. Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies. J. Gen. Virol. 72:2097-2103.
29. Lundkvist, Å., H. Kallio-Kokko, K. Brus Sjölander, et al. 1996. Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity. Virology 216:397-406.
30. Lundkvist, Å., H. Meisel, D. Koletzki, et al. 2002. Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus. Viral Immunol. 15:177-192.
31. McClain, D.J., P.L. Summers, S.A. Harrison, et al. 2000. Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J. Med. Virol. 60:77-85.
32. Mikhailov, M., K. Monastyrskaya, T. Bakker, et al. 1996. A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules. Virology 217:323-331.
33. Milich, D.R., and A. McLachlan. 1986. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234:1398-1401.
34. Miyamura, K., S. Kajigaya, M. Momoeda, et al. 1994. Parvovirus particles as platforms for protein presentation. Proc. Natl. Acad. Sci. USA 91:8507-8511.
35. Ou, W.C., M. Wang, C.Y. Fung, et al. 1999. The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. J. Gen. Virol. 80:39-46.
36. Pumpens, P., and E. Grens. 2002. Artificial genes for chimeric virus-like particles, pp. 249-327. In: Y.E. Khudyakov and H.A. Fields (eds.), Artificial DNA. Methods and applications. CRC Press, Boca Raton, FL.
37. Pushko, P., T. Kozlovskaya, I. Sominskaya, et al. 1993. Analysis of RNA phage fr coat protein assembly by insertion, deletion and substitution mutagenesis. Protein Eng. 6:883-891.
38. Reip, A., B. Haring, C. Sibold, et al. 1995. Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype. Arch. Virol. 140:2011-2026.
39. Samuel, D., K. Sasnauskas, L. Jin, et al. 2002. High level expression of recombinant mumps nucleoprotein in Saccharomyces cerevisiae and its evaluation in mumps IgM serology. J. Med. Virol. 66:123-130.
40. Sandalon, Z., N. Dalyot-Herman, A.B. Oppenheim, et al. 1997. In vitro assembly of SV40 virions and pseudovirions: vector development for gene therapy. Hum. Gene Ther. 8:843-849.
41. Sasnauskas, K., O. Buzaite, F. Vogel, et al. 1999. Yeast cells allow the high-level expression and formation of polyomavirus-like particles. Biol. Chem. 380:381-386.
42. Sasnauskas, K., A. Bulavaite, A. Hale, et al. 2002. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae. Intervirology 45:308-317.
43. Schäfer, K., M. Müller, S. Faath, et al. 1999. Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection. Int. J. Cancer 81:881-888.
44. Scherneck, S., R. Ulrich, and J. Feunteun. 2001. The hamster polyomavirus - a brief review of recent knowledge. Virus Genes 22:93-101.
45. Schirmbeck, R., W. Böhm, and J. Reimann. 1996. Virus-like particles induce MHC class 1-restricted T-cell responses. Intervirology 39:111-119.
46. Schödel, F., A.M. Moriarty, D.L. Peterson, et al. 1992. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J. Virol. 66:106-114.
47. Sibold, C., H. Meisel, Å. Lundkvist, et al. 1999. Simultaneous occurrence of Dobrava, Puumala and Tula hantaviruses in Slovakia. Am. J. Trop. Med. Hyg. 61:409-411.
48. Siray, H., M. Özel Ozel, B. Jandrig, et al. 1998. Capsid protein-encoding genes of hamster polyomavirus and properties of the viral capsid. Virus Genes 18:39-47.
49. Siray, H., C. Frömmel, T. Voronkova, et al. 2000. An immunodominant, cross-reactive B-cell epitope region is located at the C-terminal part of hamster polyomavirus major capsid protein VP1. Viral Immunol. 13:533-545.
50. Szomolanyi-Tsuda, E., Q.P. Le, R.L. Garcea, et al. 1998. T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J. Virol. 72:6665-6670.
51. Szomolanyi-Tsuda, E., J.D. Brien, J.E. Dorgan, et al. 2001. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology 280:160-168.
52. Ulrich, R., M. Nassal, H. Meisel, et al. 1998. Core particles of hepatitis B virus as carrier for foreign epitopes. Adv. Virus Res. 50:141-182.
53. Ulrich, R., G.P. Lomonossoff, and D.H. Krüger (eds.). 2002. New developments in viral vaccine technologies [Special issue]. Intervirology 45, no. 4-6.
54. Voronkova, T., A. Grosch, A. Kazaks, et al. 2002. Chimeric bacteriophage fr virus-like particles harboring the immunodominant C-terminal region of hamster polyomavirus VP1 induce a strong VP1-specific antibody response in rabbits and mice. Viral Immunol. 15:627-644.
55. Wagner, R., V.J. Teeuwsen, L. Deml, et al. 1998. Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection. Virology 245:65-74.
56. Zöller, L.G., S. Yang, P. Gött, et al. 1993. A novel μ-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome. J. Clin. Microbiol. 31:1194-1199.